CNR2 and HIV-associated neurocognitive disorder: Importantly, these shifts in CB1 and CB2 expression may be dependent on cell-types and therefore could indicate that therapies designed to target these receptors or other ECS proteins in neurons or glial cells may be beneficial for patients with HAND.